Boswood, A (2018) Improving outcomes of myxomatous mitral valve disease in dogs. IN PRACTICE, 40 (1). pp. 12-15.
Full text not available from this repository.Abstract
Now that treatment has been shown to slow the onset of clinical signs of myxomatous mitral valve disease (MMVD), recommendations are focusing on diagnosing the condition before clinical signs manifest so that dogs can be maintained free of signs for longer. This article summarises the published evidence and outlines optimal management for dogs at each disease stage. It covers pharmacological and other strategies, with a view to maintaining dogs in the early stages of the disease for as long as possible and effectively managing their clinical signs when they develop.
| Item Type: | Article |
|---|---|
| RVC Publication Type: | Journal Article |
| WoS ID: | 000429425900004 |
| DOI: | https://doi.org/10.1136/inp.k915 |
| Departments: | Clinical Sciences and Services |
| Research Programmes: | Comparative Physiology & Medicine > Cardiovascular and Inflammation Biology and Metabolism |
| Depositing User: | RVC Auto-import |
| Last Modified: | 21 Nov 2020 01:07 |
| URI: | https://researchonline.rvc.ac.uk/id/eprint/11419 |
Actions (Repository Editors)
 |
View Item |